BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park JJ, Cheon JH, Kim BY, Kim DH, Kim ES, Kim TI, Lee KR, Kim WH. Correlation of serum-soluble triggering receptor expressed on myeloid cells-1 with clinical disease activity in inflammatory bowel disease. Dig Dis Sci. 2009;54:1525-1531. [PMID: 18975078 DOI: 10.1007/s10620-008-0514-5] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Chang W, Peng F, Meng SS, Xu JY, Yang Y. Diagnostic value of serum soluble triggering expressed receptor on myeloid cells 1 (sTREM-1) in suspected sepsis: a meta-analysis. BMC Immunol 2020;21:2. [PMID: 31931717 DOI: 10.1186/s12865-020-0332-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
2 Aldasoro Arguinano AA, Dadé S, Stathopoulou M, Derive M, Coumba Ndiaye N, Xie T, Masson C, Gibot S, Visvikis-Siest S. TREM-1 SNP rs2234246 regulates TREM-1 protein and mRNA levels and is associated with plasma levels of L-selectin. PLoS One 2017;12:e0182226. [PMID: 28771614 DOI: 10.1371/journal.pone.0182226] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
3 Wang Z, Chi H, Sun Y, Teng J, Feng T, Liu H, Cheng X, Ye J, Shi H, Hu Q, Jia J, Liu T, Wan L, Zhou Z, Qiao X, Yang C, Su Y. Serum sTREM-1 in adult-onset Still's disease: a novel biomarker of disease activity and a potential predictor of the chronic course. Rheumatology (Oxford) 2020;59:3293-302. [PMID: 32276274 DOI: 10.1093/rheumatology/keaa135] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Bassyouni IH, Fawzi S, Gheita TA, Bassyouni RH, Nasr AS, El Bakry SA, Afifi N. Clinical Association of a Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) in Patients with Systemic Lupus Erythematosus. Immunol Invest 2017;46:38-47. [PMID: 27648678 DOI: 10.1080/08820139.2016.1211140] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
5 李维维, 唐国都, 梁志海, 詹媛, 方春芸. TREM-1在大鼠急性坏死性胰腺炎并肝损伤中的作用. 世界华人消化杂志 2014; 22(28): 4223-4230 [DOI: 10.11569/wcjd.v22.i28.4223] [Reference Citation Analysis]
6 Choi ST, Kang EJ, Ha YJ, Song JS. Levels of plasma-soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) are correlated with disease activity in rheumatoid arthritis. J Rheumatol 2012;39:933-8. [PMID: 22422501 DOI: 10.3899/jrheum.111218] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
7 Han L, Fu L, Peng Y, Zhang A. Triggering Receptor Expressed on Myeloid Cells-1 Signaling: Protective and Pathogenic Roles on Streptococcal Toxic-Shock-Like Syndrome Caused by Streptococcus suis. Front Immunol 2018;9:577. [PMID: 29619033 DOI: 10.3389/fimmu.2018.00577] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
8 Kourkoulis P, Kapizioni C, Michalopoulos G, Andreou N, Papaconstantinou I, Karamanolis G, Gazouli M. Novel potential biomarkers for the diagnosis and monitoring of patients with ulcerative colitis. European Journal of Gastroenterology & Hepatology 2019;31:1173-83. [DOI: 10.1097/meg.0000000000001490] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Bostanci N, Oztürk VÖ, Emingil G, Belibasakis GN. Elevated oral and systemic levels of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) in periodontitis. J Dent Res 2013;92:161-5. [PMID: 23242230 DOI: 10.1177/0022034512470691] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
10 Jung ES, Kim SW, Moon CM, Shin DJ, Son NH, Kim ES, Lee HJ, Hong SP, Kim TI, Kim WH, Cheon JH. Relationships between genetic polymorphisms of triggering receptor expressed on myeloid cells-1 and inflammatory bowel diseases in the Korean population. Life Sci 2011;89:289-94. [PMID: 21763322 DOI: 10.1016/j.lfs.2011.06.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
11 Belibasakis GN, Öztürk V, Emingil G, Bostanci N. Soluble Triggering Receptor Expressed on Myeloid Cells 1 (sTREM-1) in Gingival Crevicular Fluid: Association With Clinical and Microbiologic Parameters. Journal of Periodontology 2014;85:204-10. [DOI: 10.1902/jop.2013.130144] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
12 Sachar DB; Biomarkers Task Force of the IOIBD. Role of biomarkers in the study and management of inflammatory bowel disease: a "nonsystematic" review. Inflamm Bowel Dis 2014;20:2511-8. [PMID: 25222663 DOI: 10.1097/MIB.0000000000000135] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
13 Bisson C, Massin F, Lefevre PA, Thilly N, Miller N, Gibot S. Increased gingival crevicular fluid levels of soluble triggering receptor expressed on myeloid cells (sTREM) -1 in severe periodontitis. J Clin Periodontol 2012;39:1141-8. [PMID: 23067264 DOI: 10.1111/jcpe.12008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
14 Kim ES, Kim WH. Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics. Gut Liver. 2010;4:1-14. [PMID: 20479907 DOI: 10.5009/gnl.2010.4.1.1] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 5.7] [Reference Citation Analysis]
15 Yin K, Dang SC, Zhang JX. Relationship between expression of triggering receptor-1 on myeloid cells in intestinal tissue and intestinal barrier dysfunction in severe acute pancreatitis. World J Emerg Med 2011;2:216-21. [PMID: 25215013 DOI: 10.5847/wjem.j.1920-8642.2011.03.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
16 Schey R, Danzer C, Mattner J. Perturbations of mucosal homeostasis through interactions of intestinal microbes with myeloid cells. Immunobiology 2015;220:227-35. [PMID: 25466587 DOI: 10.1016/j.imbio.2014.11.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
17 Saurer L, Rihs S, Birrer M, Saxer-Seculic N, Radsak M, Mueller C. Elevated levels of serum-soluble triggering receptor expressed on myeloid cells-1 in patients with IBD do not correlate with intestinal TREM-1 mRNA expression and endoscopic disease activity. J Crohns Colitis. 2012;6:913-923. [PMID: 22410349 DOI: 10.1016/j.crohns.2012.02.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
18 Yang C, Chen B, Zhao J, Lin L, Han L, Pan S, Fu L, Jin M, Chen H, Zhang A. TREM-1 signaling promotes host defense during the early stage of infection with highly pathogenic Streptococcus suis. Infect Immun 2015;83:3293-301. [PMID: 26056380 DOI: 10.1128/IAI.00440-15] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
19 Essa ES, Elzorkany KM. sTREM-1 in patients with chronic kidney disease on hemodialysis. APMIS 2015;123:969-74. [PMID: 26495896 DOI: 10.1111/apm.12459] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
20 Jaoude PA, Knight PR, Ohtake P, El-Solh AA. Biomarkers in the diagnosis of aspiration syndromes. Expert Rev Mol Diagn 2010;10:309-19. [PMID: 20370588 DOI: 10.1586/erm.10.7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
21 Tammaro A, Derive M, Gibot S, Leemans JC, Florquin S, Dessing MC. TREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectives. Pharmacol Ther 2017;177:81-95. [PMID: 28245991 DOI: 10.1016/j.pharmthera.2017.02.043] [Cited by in Crossref: 71] [Cited by in F6Publishing: 69] [Article Influence: 17.8] [Reference Citation Analysis]
22 Jung YS, Park JJ, Kim SW, Hong SP, Kim TI, Kim WH, Cheon JH. Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases. Dig Liver Dis 2012;44:897-903. [PMID: 22721842 DOI: 10.1016/j.dld.2012.05.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
23 Lee HJ, Shin HS, Jang HW, Kim SW, Park SJ, Hong SP, Kim TI, Kim WH, Cheon JH. Correlation between soluble triggering receptor expressed on myeloid cells-1 and endoscopic activity in intestinal Behçet's disease. Yonsei Med J 2014;55:960-6. [PMID: 24954324 DOI: 10.3349/ymj.2014.55.4.960] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
24 Jung YS, Kim SW, Yoon JY, Lee JH, Jeon SM, Hong SP, Kim TI, Kim WH, Cheon JH. Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet’s disease. Inflamm Bowel Dis. 2011;17:2130-2137. [PMID: 21910175 DOI: 10.1002/ibd.21600] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
25 Chung SH, Lee HW, Kim SW, Park SJ, Hong SP, Kim TI, Kim WH, Cheon JH. Usefulness of Measuring Serum Procalcitonin Levels in Patients with Inflammatory Bowel Disease. Gut Liver. 2016;10:574-580. [PMID: 26780089 DOI: 10.5009/gnl15209] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
26 Ugurlu S, Egeli BH, Bolayirli IM, Ozdogan H. Soluble TREM-1 Levels in Familial Mediterranean Fever Related AA-Amyloidosis. Immunol Invest 2021;50:273-81. [PMID: 32321335 DOI: 10.1080/08820139.2020.1751195] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
27 Liu Q, Johnson EM, Lam RK, Wang Q, Bo Ye H, Wilson EN, Minhas PS, Liu L, Swarovski MS, Tran S, Wang J, Mehta SS, Yang X, Rabinowitz JD, Yang SS, Shamloo M, Mueller C, James ML, Andreasson KI. Peripheral TREM1 responses to brain and intestinal immunogens amplify stroke severity. Nat Immunol 2019;20:1023-34. [PMID: 31263278 DOI: 10.1038/s41590-019-0421-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 16.5] [Reference Citation Analysis]
28 Genua M, Rutella S, Correale C, Danese S. The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis. J Transl Med 2014;12:293. [PMID: 25347935 DOI: 10.1186/s12967-014-0293-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
29 Yuan Z, Syed M, Panchal D, Joo M, Bedi C, Lim S, Onyuksel H, Rubinstein I, Colonna M, Sadikot RT. TREM-1-accentuated lung injury via miR-155 is inhibited by LP17 nanomedicine. Am J Physiol Lung Cell Mol Physiol 2016;310:L426-38. [PMID: 26684249 DOI: 10.1152/ajplung.00195.2015] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
30 Hyder LA, Gonzalez J, Harden JL, Johnson-Huang LM, Zaba LC, Pierson KC, Eungdamrong NJ, Lentini T, Gulati N, Fuentes-Duculan J, Suárez-Fariñas M, Lowes MA. TREM-1 as a potential therapeutic target in psoriasis. J Invest Dermatol 2013;133:1742-51. [PMID: 23407402 DOI: 10.1038/jid.2013.68] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Hyder LA, Gonzalez J, Harden JL, Johnson-Huang LM, Zaba LC, Pierson KC, Eungdamrong NJ, Lentini T, Gulati N, Fuentes-Duculan J, Suárez-Fariñas M, Lowes MA. TREM-1 as a potential therapeutic target in psoriasis. J Invest Dermatol 2013;133:1742-51. [PMID: 23407402 DOI: 10.1038/jid.2013.68] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
32 Gao S, Yi Y, Xia G, Yu C, Ye C, Tu F, Shen L, Wang W, Hua C. The characteristics and pivotal roles of triggering receptor expressed on myeloid cells-1 in autoimmune diseases. Autoimmun Rev 2019;18:25-35. [PMID: 30408584 DOI: 10.1016/j.autrev.2018.07.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
33 Kusanovic JP, Romero R, Chaiworapongsa T, Mittal P, Mazaki-Tovi S, Vaisbuch E, Erez O, Gotsch F, Than NG, Edwin SS, Pacora P, Jodicke C, Yeo L, Hassan SS. Amniotic fluid sTREM-1 in normal pregnancy, spontaneous parturition at term and preterm, and intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med 2010;23:34-47. [PMID: 19591072 DOI: 10.3109/14767050903009248] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
34 Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H. TREM-1 Contributes to Inflammation in IgA Nephropathy. Kidney Dis (Basel) 2018;4:29-36. [PMID: 29594140 DOI: 10.1159/000485622] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
35 Barraud D, Gibot S. Triggering receptor expressed on myeloid cell 1. Crit Care Clin 2011;27:265-79. [PMID: 21440201 DOI: 10.1016/j.ccc.2010.12.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
36 Derive M, Massin F, Gibot S. Triggering receptor expressed on myeloid cells-1 as a new therapeutic target during inflammatory diseases. Self Nonself 2010;1:225-30. [PMID: 21487478 DOI: 10.4161/self.1.3.12891] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
37 Dang S, Shen Y, Yin K, Zhang J. TREM-1 Promotes Pancreatitis-Associated Intestinal Barrier Dysfunction. Gastroenterol Res Pract. 2012;2012:720865. [PMID: 22611379 DOI: 10.1155/2012/720865] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
38 Raggi F, Bosco MC. Targeting Mononuclear Phagocyte Receptors in Cancer Immunotherapy: New Perspectives of the Triggering Receptor Expressed on Myeloid Cells (TREM-1). Cancers (Basel) 2020;12:E1337. [PMID: 32456204 DOI: 10.3390/cancers12051337] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
39 Öztürk VÖ, Belibasakis GN, Emingil G, Bostanci N. Impact of aging on TREM-1 responses in the periodontium: a cross-sectional study in an elderly population. BMC Infect Dis 2016;16:429. [PMID: 27542376 DOI: 10.1186/s12879-016-1778-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
40 Ford JW, McVicar DW. TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol. 2009;21:38-46. [PMID: 19230638 DOI: 10.1016/j.coi.2009.01.009] [Cited by in Crossref: 278] [Cited by in F6Publishing: 277] [Article Influence: 23.2] [Reference Citation Analysis]
41 Tomita H, Ogawa F, Hara T, Yanaba K, Iwata Y, Muroi E, Yoshizaki A, Komura K, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S. Elevated Serum Concentrations of Triggering Receptor Expressed on Myeloid Cells-1 in Diffuse Cutaneous Systemic Sclerosis: Association with Severity of Pulmonary Fibrosis. J Rheumatol 2010;37:787-91. [DOI: 10.3899/jrheum.090664] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
42 Billioud V, Gibot S, Massin F, Oussalah A, Chevaux J, Williet N, Bronowicki J, Bigard M, Guéant J, Peyrin-biroulet L. Plasma soluble triggering receptor expressed on myeloid cells-1 in Crohn's disease. Digestive and Liver Disease 2012;44:466-70. [DOI: 10.1016/j.dld.2012.01.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
43 Cao C, Gu J, Zhang J. Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a potential biomarker for the diagnosis of infectious diseases. Front Med 2017;11:169-77. [PMID: 28425045 DOI: 10.1007/s11684-017-0505-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
44 Harmanci K, Akan OY, Pirildar T, Ortan P, Ulman C. The Evaluation of the Relationship between sTREM-1, VEGF-B, and VEGF Gene Expression Levels with Disease Activity of Behçet's Patients. Dis Markers 2018;2018:2649392. [PMID: 30420902 DOI: 10.1155/2018/2649392] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
45 Lagha AB, Grenier D. Tea polyphenols inhibit the activation of NF-κB and the secretion of cytokines and matrix metalloproteinases by macrophages stimulated with Fusobacterium nucleatum. Sci Rep 2016;6:34520. [PMID: 27694921 DOI: 10.1038/srep34520] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
46 Haller-Kikkatalo K, Sarapik A, Faure GC, Béné MC, Massin F, Salumets A, Uibo R. Serum sTREM-1 (soluble triggering receptor expressed on myeloid cells-1) associates negatively with embryo quality in infertility patients. Am J Reprod Immunol 2012;68:68-74. [PMID: 22229451 DOI: 10.1111/j.1600-0897.2011.01102.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
47 Nguyen AH, Berim IG, Agrawal DK. Chronic inflammation and cancer: emerging roles of triggering receptors expressed on myeloid cells. Expert Rev Clin Immunol 2015;11:849-57. [PMID: 25954917 DOI: 10.1586/1744666X.2015.1043893] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
48 Rohde G, Radsak MP, Borg I, Buhl R, Schultze-Werninghaus G, Taube C. Levels of soluble triggering receptor expressed on myeloid cells 1 in infectious exacerbations of chronic obstructive pulmonary disease. Respiration 2012;83:133-9. [PMID: 21701149 DOI: 10.1159/000328413] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
49 Schäffler H, Rohde M, Rohde S, Huth A, Gittel N, Hollborn H, Koczan D, Glass Ä, Lamprecht G, Jaster R. NOD2- and disease-specific gene expression profiles of peripheral blood mononuclear cells from Crohn’s disease patients. World J Gastroenterol 2018; 24(11): 1196-1205 [PMID: 29568200 DOI: 10.3748/wjg.v24.i11.1196] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
50 Abdel-Aziz H, Schneider M, Neuhuber W, Meguid Kassem A, Khailah S, Müller J, Gamal Eldeen H, Khairy A, T Khayyal M, Shcherbakova A, Efferth T, Ulrich-Merzenich G. GPR84 and TREM-1 Signaling Contribute to the Pathogenesis of Reflux Esophagitis. Mol Med 2016;21:1011-24. [PMID: 26650186 DOI: 10.2119/molmed.2015.00098] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
51 Yoon JY, Park SJ, Hong SP, Kim TI, Kim WH, Cheon JH. Correlations of C-reactive protein levels and erythrocyte sedimentation rates with endoscopic activity indices in patients with ulcerative colitis. Dig Dis Sci 2014;59:829-37. [PMID: 24352705 DOI: 10.1007/s10620-013-2907-3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
52 Natale G, Biagioni F, Busceti CL, Gambardella S, Limanaqi F, Fornai F. TREM Receptors Connecting Bowel Inflammation to Neurodegenerative Disorders. Cells 2019;8:E1124. [PMID: 31546668 DOI: 10.3390/cells8101124] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
53 Forrester DL, Barr HL, Fogarty A, Knox A. sTREM-1 is elevated in cystic fibrosis and correlates with proteases. Pediatr Pulmonol 2017;52:467-71. [PMID: 28068000 DOI: 10.1002/ppul.23650] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
54 Latour-Pérez J, Alcalá-López A, García-García MA, Sánchez-Hernández JF, Abad-Terrado C, Viedma-Contreras JA, Masiá M, González-Tejera M, Arizo-León D, Porcar MJ, Bonilla-Rovira F, Gutiérrez F. Diagnostic accuracy of sTREM-1 to identify infection in critically ill patients with systemic inflammatory response syndrome. Clin Biochem 2010;43:720-4. [PMID: 20303344 DOI: 10.1016/j.clinbiochem.2010.03.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]